Comment on "The abrupt cessation of therapeutically administered sodium oxybate (GHB) may cause withdrawal symptoms"

J Toxicol Clin Toxicol. 2004;42(1):121-3; author reply 125-7. doi: 10.1081/clt-120028759.
No abstract available

Publication types

  • Comment
  • Letter
  • Review

MeSH terms

  • Cataplexy / complications
  • Cataplexy / physiopathology
  • Humans
  • Retrospective Studies
  • Sodium Oxybate / adverse effects*
  • Substance Withdrawal Syndrome / etiology*
  • Substance Withdrawal Syndrome / physiopathology

Substances

  • Sodium Oxybate